Substance Use Tools & Resources    

This is a toolkit on addressing pain in patients with opioid use disorder (OUD) and managing medication for addiction treatment (MAT) during the perioperative/postpartum period.

Shows State-level geographic comparisons of de-identified Medicaid opioid prescriptions filled within the United States. The mapping tool is interactive and presents Medicaid opioid prescribing rates for 2016 as well as the change in opioid prescribing rates from 2013 to 2016.

Includes profiles for all 50 States that detail the State authority for controlled substances and links to any relevant regulations, rules, and prescription drug monitoring programs.

NEJM Knowledge+ Pain Management and Opioids module covers the latest practices for assessing and managing patients' acute and chronic pain, current guidelines on the appropriate use of opioids for pain management, and evidence-based strategies for recognizing and treating opioid use.

Details the material risks associated with the medication and risk of physical dependence.

Supplies guidelines for 11 medical specialties on the safe and effective use of opioids in the treatment of pain.

Provides a sample treatment agreement that describes the patient's responsibilities as well as the risks and side effects of using opioid medications.

This module features more than 60 case-based questions on pain management, safer prescribing of opioid analgesics, and the recognition and treatment of opioid use disorder. To ensure the development of high-quality, unbiased content in this module, we partnered with experts at Boston University School of Medicine's Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program.

Provides pharmacists with information about prescription opioid use in the United States, the role of pharmacists as part of the pain management team and in preventing opioid use disorder, and communication with patients.

Describes Virginia's Prescription Monitoring Program, including benefits, user testimonials, an informational brochure, and program milestones. Features statistical data about use of the program and prescription drugs, changes in regulations for registered system users, and feature articles for patients.